Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05224713 · ClinicalTrials.gov registry record
Correlations Between Press Ganey Hospital and Ambulatory Scores for a Neurosurgical Practice
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 1,800
- Enrollment target
NCT05224713: Completed study, sponsored by Methodist Health System.
NCT05224713 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 1,800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05224713 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 1,800 participants
- Enrollment target
Study Summary
This will be a retrospective review of MHS neurosurgeon hospital (i.e., Methodist Dallas Medical Center, Methodist Richardson Medical Center, Methodist Charlton Medical Center, and Methodist Mansfield Medical Center) and ambulatory clinics (Methodist Moody Brain and Spine Institute \[MBSI\]- Dallas, MBSI-Richardson, MBSI-Mansfield, MBSI-Sunnyvale, MBSI-Charlton, MBSI-Grand Prairie, and MBSI-Park Cities) PG HCAHPS survey results received between January 1, 2016 and December 31, 2020.
Primary Outcome
includes: friendliness/courtesy of CP; CP explanations of problems/condition; CP concern for questions/worries; CP efforts to include in decisions; CP information about medications; CP instructions for follow-up care; CP spoke using clear language; time CP spent with patient; patients' confidence in CP; and likelihood of recommending CP.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2023-07-06 |
| Est. Completion | 2025-07-18 |
What the finished NCT05224713 record still lists
NCT05224713 is an observational study that tracks outcomes without assigning an intervention. Its 1,800 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT05224713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05224713 about?
NCT05224713 is a clinical study titled "Correlations Between Press Ganey Hospital and Ambulatory Scores for a Neurosurgical Practice". This will be a retrospective review of MHS neurosurgeon hospital (i.e., Methodist Dallas Medical Center, Methodist Richardson Medical Center, Methodist Charlton Medical Center, and Methodist Mansfield Medical Center) and ambulatory clinics (Methodist Moody Brain and Spine Institute \[MBSI\]- Dallas,...
What is the current status of trial NCT05224713?
This trial is currently completed. The enrollment target is 1,800 participants. The study started on 2023-07-06. Estimated completion is 2025-07-18.
Who is sponsoring clinical trial NCT05224713?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI